SignIn
Kerala Kaumudi Online
Wednesday, 22 September 2021 7.46 PM IST

Decision on EUL of Covaxin likely in 4-6 weeks: WHO

covaxin-

GENEVA: The World Health Organisation (WHO) is likely to take a decision on Emergency Use Listing (EUL) of Bharat Biotech's Covaxin and announce it in the first week of August.


A WHO pre-qualification, or EUL, is necessary for a vaccine company to supply vaccines for global facilities such as Covax or international procurement.

The WHO has approved vaccines Pfizer-BioNTech, AstraZeneca- SK Bio/SII, Johnson & Johnson Janssen, Moderna and Sinopharm for emergency use.


The indigenous vaccine showed 63.6 per cent efficacy against the Delta variant of Covid-19, which has spread in many other countries.


Covaxin demonstrated 93.4 per cent efficacy against severe symptomatic Covid-19 and 63.6 per cent against asymptomatic Covid-19.


The trial was conducted on 25,800 subjects, and the data submitted to the Subject Expert Committee (SEC) showed the vaccine was "well-tolerated."

JOIN THE DISCUSSION
TAGS: WHO, EUL, COVAXIN
KERALA KAUMUDI EPAPER
TRENDING IN INDIA
TRENDING IN INDIA
X
Lorem ipsum dolor sit amet
consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
We respect your privacy. Your information is safe and will never be shared.